Viral rebound after Paxlovid therapy — what do we know?
Cases of viral rebound or COVID-19 rebound are being reported after Paxlovid therapy. Here’s what health care practitioners should know about Paxlovid efficacy and rebound.
Read
COVID-19
-
-
COVID-19 vaccine safety during IVF
A new study adds to a growing body of evidence that COVID-19 vaccines do not negatively impact reproductive potential.
Read
-
PrEP and PEP: Can medications work to prevent COVID-19?
Vaccination remains the most effective method to prevent severe outcomes of COVID-19, but what do we know about medications for pre-exposure and post-exposure prophylaxis?
Read
-
Outpatient therapy for COVID-19: What are the options and who is eligible?
Two categories of COVID-19-directed therapy are now available to high-risk outpatients: monoclonal antibody therapy and antiviral agents. DynaMed editors share what they know about them.
Read
-
COVID-19 in 2022: 10 things you need to know now
We are entering 2022 with vaccines, treatments, and yes, new variants. Here are answers to ten questions you may have about COVID-19 as we usher in the new year.
Read
-
Determining COVID-19 vaccine dosing regimens
Pharmacokinetic profiles guide drug dosing regimens, but how are vaccine dosing regimens determined? DynaMed editors break down this difference and illustrate the influence of age.
Read
-
Top 5 questions about the Omicron variant
Editors at DynaMed share what you need to know about Omicron, the COVID-19 variant that’s spreading rapidly around the globe.
Read
-
Top 10: Most-read COVID-19 articles in ClinicalKey from last year
Vaccines and prevention, treatments and complications associated with the disease are among the prevalent themes in these popular COVID-19 ClinicalKey articles published in 2021.
Read
-
Ask a Librarian: post-COVID-19 condition (long COVID)
Joule’s Ask a Librarian team curates free evidence-based resources on post‒COVID-19 condition, also known as long COVID.
Read
-
An antiviral pill for COVID-19 — is molnupiravir too good to be true?
Molnupiravir is a new antiviral pill to treat COVID-19. Here’s what we know so far.
Read
-
Answers to questions about COVID-19 booster shots
Answers to common questions about COVID-19 booster shots from medical experts at DynaMed.
Read
-
COVID-19 vaccines, Delta and data — it’s all in the math
DynaMed’s editorial team debunks misinformation about COVID-19 infections in vaccinated people, the delta variant and immunity concerns.
Read
-
5 answers to questions about COVID-19 vaccines for children and adolescents
What is the status of SARS-CoV-2 vaccines for children? What do we know about their efficacy and safety for adolescents? The editorial team at DynaMed shares evidence to answer them.
Read
-
Rated by Canada’s physicians: 2020’s top POEMs were about COVID-19 prevention
The four highest-rated POEMs for 2020 overall, and 5 of the top 20 highest-rated POEMs for clinical relevance, were on COVID-19 prevention.
Read
-
Updated information on SARS-CoV-2 Variants of Concern (VOC)
The editorial team at DynaMed shares new information on SARS-CoV-2 Variants of Concern including the updated naming convention defined by WHO.
Read
-
SARS-CoV-2 reinfection: what do we know so far?
How long does immunity to SARS-CoV-2 last? The editorial team at DynaMed shares the evidence on this topic.
Read
-
The doc is on TikTok: how physicians are using social media to build vaccine confidence
Medical experts across Canada are using their personal social media platforms to share information about COVID-19 vaccines
Read
-
Answers to four common questions about Post-Acute COVID-19 Syndrome / Long COVID
Meta description: What is long COVID? And how do you treat it? The editorial team at DynaMed shares evidence on the condition
Read
-
Adenovirus-vectored vaccines for COVID-19 – how do they work?
Many people are curious about how adenovirus-vectored vaccines work for COVID-19. The editorial team at DynaMed provides a sneak peek.
Read
-
How Black medical experts are building trust within Black communities about vaccines
"People are suspicious": Black physicians and scientists use virtual town halls to tackle COVID-19 vaccine hesitancy
Read
-
Loading More...
